保妇康栓联合阿奇霉素对支原体宫颈炎疗效及复发率分析

Analysis of the Efficacy and Recurrence Rate of Baofukang Suppository Combined with Azithromycin in the Treatment of Mycoplasma Cervicitis

目的:分析在支原体宫颈炎患者的治疗中应用保妇康栓联合阿奇霉素治疗的疗效以及对复发率的影响。方法:选取2022年2月—2023年2月南阳市第二人民医院接受治疗的支原体宫颈炎患者作为研究对象,采集样本例数为80例,将这80例患者按照单双号法进行分组,分成研究组与常规组,其中常规组(40例)患者采用阿奇霉素进行治疗,研究组(40例)患者采用保妇康栓联合阿奇霉素治疗。两组患者的复发率、白带清洁度(av)评分、阴道镜量化(RCI)评分、临床症状评分、生活质量、心理状态以及舒适度等指标进行分析比较。结果:研究组患者的复发率(5.00%)低于常规组(22.50%),差异有统计学意义(χ^(2)=5.164,P<0.05);治疗后,研究组患者的白带av与阴道镜RCI均明显低于常规组,差异有统计学意义(t=43.560、27.844,P<0.05);治疗后,研究组患者的阴道出血、白带增多、腰部疼痛、下腹不适等评分均明显低于常规组,差异有统计学意义(t=18.432、22.027、17.531、18.835,P<0.05);治疗后,研究组患者的躯体健康、社会功能、日常生活、精神健康等评分均明显高于常规组,差异有统计学意义(t=17.752、36.807、32.199、47.762,P<0.05);治疗后,研究组患者的紧张、焦虑、烦躁、不安等评分均明显低于常规组,差异有统计学意义(t=17.996、26.046、17.816、47.812,P<0.05);治疗后,研究组患者的心理舒适、生理舒适、治疗舒适、环境舒适等评分均高于常规组,差异有统计学意义(t=41.684,38.375,51.222,40.697,P<0.05)。结论:对于支原体宫颈炎患者来说,应采用保妇康栓联合阿奇霉素进行治疗,这种治疗方式可以改善患者心理状态与临床症状,降低患者白带av评分与阴道镜RCI评分以及复发率,同时提升患者舒适度与生活质量。

Objective:To analyze the efficacy of Baofukang Suppository combined with Azithromycin in the treatment of patients with Mycoplasma cervicitis and its impact on recurrence rate.Methods:Patients with mycoplasma cervicitis who received treatment in the hospital from February 2022 to February 2023 were selected as samples.80 patients were collected and divided into two different groups:the study group and the conventional group.Among them,40 patients in the conventional group were treated with azithromycin.40 patients in the study group were treated with Baofukang Suppository combined with Azithromycin.Recurrence rate,vaginal discharge score(av)and colposcopy RCI score,clinical symptom score,quality of life,psychological status and comfort of the two groups were analyzed and compared.Results:The recurrence rate of patients in the study group(5.00%)was significantly lower than that in the conventional group(22.50%),and there was a statistically significant difference between the groups(χ^(2)=5.164,P<0.05).After treatment,av and RCI scores of vaginal discharge in the study group were significantly lower than those in the conventional group,with statistically significant difference(t=43.560,27.844;P<0.05).After treatment,the scores of vaginal bleeding,increased vaginal discharge,lower back pain,and lower abdominal discomfort in the study group were significantly lower than those in the conventional group,with statistically significant difference(t=18.432,22.027,17.531,18.835;P<0.05).After treatment,the physical health,social function,daily life and mental health scores of the study group were significantly higher than the conventional group,with statistically significant difference(t=17.752,36.807,32.199,47.762;P<0.05).After treatment,the scores of tension,anxiety,irritability and unease in the study group were significantly lower than those in the conventional group,with statistically significant difference(t=17.996,26.046,17.816,47.812;P<0.05).After treatment,the scores of psychological comfort,physiological comfort,treatment comfort and environmental comfort in the study group were higher than those in the conventional group,with statistically significant difference(t=41.684,38.375,51.222,40.697;P<0.05).Conclusion:For patients with mycoplasma cervicitis,Baofukang suppository combined with Azithromycin should be used for treatment.This treatment method can improve the patient’s psychological state and clinical symptoms,reduce the patients’AV and RCI scores,as well as the recurrence rate.At the same time,it improves the patient’s comfort and quality of life.